Literature DB >> 12871657

Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats.

D M Sokal1, S J R Elmes, D A Kendall, V Chapman.   

Abstract

Anti-nociceptive effects of the endocannabinoid anandamide are well established. Anandamide has, however, also been shown to activate pro-nociceptive vanilloid 1 (VR1) receptors present on primary afferent nociceptors. The aim of the present study was to determine the effect of intraplantar injection of anandamide on dorsal spinal neuronal responses in control rats and rats with hindpaw carrageenan-induced inflammation. Effects of intraplantar administration of anandamide (50 microg in 50 microl) on peripheral mechanically-evoked responses of spinal neurones were studied in halothane-anaesthetised rats in vivo. Responses of spinal neurones to mechanical punctate stimulation (von Frey filaments, 8-80 g) of the peripheral receptive field were similar in non-inflamed rats and rats with hindpaw carrageenan-induced inflammation. Intraplantar injection of anandamide, but not vehicle, significantly (P<0.05) inhibited innocuous and noxious mechanically-evoked responses of spinal neurones in rats with hindpaw inflammation, but not in non-inflamed rats. Co-administration of the cannabinoid (2) (CB(2)) receptor antagonist, SR144528 (10 microg in 50 microl), but not the cannabinoid (1) (CB(1)) receptor antagonist, SR141716A (10 microg in 50 microl), significantly blocked inhibitory effects of anandamide on peripheral evoked neuronal responses in rats with hindpaw inflammation. This study demonstrates inhibitory effects of exogenous anandamide on mechanically-evoked responses under inflammatory conditions in vivo, which are mediated by peripheral CB(2) receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871657     DOI: 10.1016/s0028-3908(03)00195-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  23 in total

Review 1.  [Cannabinoids--signal transduction and mode of action].

Authors:  R Rukwied; B Gauter; M Schley; C Konrad
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

2.  Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs. spinally-innervated skin.

Authors:  Jessica Marie Spradley; Auva Davoodi; Leland Bruce Gee; Mirela Iodi Carstens; E Carstens
Journal:  Neuropharmacology       Date:  2012-06-06       Impact factor: 5.250

3.  Continuous infusion of the cannabinoid WIN 55,212-2 to the site of a peripheral nerve injury reduces mechanical and cold hypersensitivity.

Authors:  I J Lever; T M Pheby; A S C Rice
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

Review 4.  The endocannabinoid system and pain.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

5.  Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase.

Authors:  L Thors; J J Burston; B J Alter; M K McKinney; B F Cravatt; R A Ross; R G Pertwee; R W Gereau; J L Wiley; C J Fowler
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

6.  Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors.

Authors:  Sandra Holt; Francesca Comelli; Barbara Costa; Christopher J Fowler
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 7.  Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain.

Authors:  Maulik D Jhaveri; Devi R Sagar; Steven J R Elmes; David A Kendall; Victoria Chapman
Journal:  Mol Neurobiol       Date:  2007-10-02       Impact factor: 5.590

8.  Functional role of cannabinoid receptors in urinary bladder.

Authors:  Pradeep Tyagi; Vikas Tyagi; Naoki Yoshimura; Michael Chancellor
Journal:  Indian J Urol       Date:  2010 Jan-Mar

Review 9.  β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia.

Authors:  Kirsten M Raehal; Laura M Bohn
Journal:  Handb Exp Pharmacol       Date:  2014

10.  Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation.

Authors:  Carl Potenzieri; Thaddeus S Brink; Cholawat Pacharinsak; Donald A Simone
Journal:  J Neurophysiol       Date:  2008-09-10       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.